Carmichael Hill & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$15K 856
2022
Q3
$15K Hold
100
0.01% 519
2022
Q2
$17K Hold
100
0.01% 498
2022
Q1
$19K Buy
100
+50
+100% +$9.88K 0.01% 511
2021
Q4
$12K Hold
50
0.01% 599
2021
Q3
$10K Hold
50
0.01% 609
2021
Q2
$9K Hold
50
﹤0.01% 617
2021
Q1
$8K Hold
50
﹤0.01% 612
2020
Q4
$8K Hold
50
﹤0.01% 586
2020
Q3
$8K Buy
+50
New +$7.68K 0.01% 555

Other funds holding ZTS

Carmichael Hill & Associates's ZTS Position: Q4 2022 in Review

Carmichael Hill & Associates sold out of Zoetis (ZTS) in Q4 2022, closing a stake of 100 shares — an estimated $15K sold.

Carmichael Hill & Associates first reported a position in ZTS in Q3 2020 and held it in 9 quarters. The position peaked at $19K in Q1 2022. 1,520 funds tracked by Wall St. Rank hold ZTS as of Q4 2022.

  • Carmichael Hill & Associates reported no remaining Zoetis position as of Q4 2022 after selling out during the quarter.
  • Carmichael Hill & Associates sold 100 Zoetis shares in Q4 2022, an estimated $15K.
  • Carmichael Hill & Associates first reported a position in Zoetis in Q3 2020 and held it in 9 quarters.
  • Carmichael Hill & Associates's Zoetis position peaked at $19K in Q1 2022.
  • 1,520 funds tracked by Wall St. Rank held Zoetis as of Q4 2022.

Based on Carmichael Hill & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.